Mechanisms of the resistance and tolerance to beta-lactam and glycopeptide antibiotics in pathogenic gram-positive cocci
- PMID: 20205634
- DOI: 10.2174/138955709790361557
Mechanisms of the resistance and tolerance to beta-lactam and glycopeptide antibiotics in pathogenic gram-positive cocci
Abstract
Beta-lactams are the most frequently used antimicrobials in combating infections. In the case of gram-positive bacteria resistant to beta-lactams, glycopeptides are the first choice. The occurrence, mechanisms and genetic background of the resistance of pathogenic staphylococci, streptococci and enterococci to beta-lactam and glycopeptide antibiotics were discussed. The resistances to well-established antimicrobials, as well as new agents (ceftobiprole, oritavancin, telavancin, dalbavancin) were taken into consideration in the text.
Similar articles
-
Mechanisms of resistance to antimicrobial drugs in pathogenic Gram-positive cocci.Mini Rev Med Chem. 2010 Sep;10(10):928-37. doi: 10.2174/138955710792007204. Mini Rev Med Chem. 2010. PMID: 20370697 Review.
-
Forthcoming therapeutic perspectives for infections due to multidrug-resistant Gram-positive pathogens.Clin Microbiol Infect. 2009 Mar;15(3):218-23. doi: 10.1111/j.1469-0691.2009.02740.x. Clin Microbiol Infect. 2009. PMID: 19335369 Review.
-
In vitro activity of LY333328 (oritavancin) against Gram-positive aerobic cocci and synergy with ciprofloxacin against enterococci.J Antimicrob Chemother. 2001 Aug;48(2):283-6. doi: 10.1093/jac/48.2.283. J Antimicrob Chemother. 2001. PMID: 11481302
-
Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones.Mayo Clin Proc. 2012 Feb;87(2):198-208. doi: 10.1016/j.mayocp.2011.12.003. Mayo Clin Proc. 2012. PMID: 22305032 Free PMC article. Review.
-
A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin.Pharmacotherapy. 2010 Jan;30(1):80-94. doi: 10.1592/phco.30.1.80. Pharmacotherapy. 2010. PMID: 20030476 Review.
Cited by
-
Biogenic copper and copper oxide nanoparticles to combat multidrug-resistant Staphylococcus aureus: Green synthesis, mechanisms, resistance, and future perspectives.Biotechnol Rep (Amst). 2025 May 6;46:e00896. doi: 10.1016/j.btre.2025.e00896. eCollection 2025 Jun. Biotechnol Rep (Amst). 2025. PMID: 40487876 Free PMC article. Review.
-
New Is Old, and Old Is New: Recent Advances in Antibiotic-Based, Antibiotic-Free and Ethnomedical Treatments against Methicillin-Resistant Staphylococcus aureus Wound Infections.Int J Mol Sci. 2016 Apr 25;17(5):617. doi: 10.3390/ijms17050617. Int J Mol Sci. 2016. PMID: 27120596 Free PMC article. Review.
-
Genomic Insights of First ermB-Positive ST338-SCCmecVT/CC59 Taiwan Clone of Community-Associated Methicillin-Resistant Staphylococcus aureus in Poland.Int J Mol Sci. 2022 Aug 6;23(15):8755. doi: 10.3390/ijms23158755. Int J Mol Sci. 2022. PMID: 35955887 Free PMC article.
-
Molecular Mechanisms of Drug Resistance and Epidemiology of Multidrug-Resistant Variants of Neisseria gonorrhoeae.Int J Mol Sci. 2022 Sep 10;23(18):10499. doi: 10.3390/ijms231810499. Int J Mol Sci. 2022. PMID: 36142410 Free PMC article. Review.
-
Molecular Mechanisms of Drug Resistance in Staphylococcus aureus.Int J Mol Sci. 2022 Jul 22;23(15):8088. doi: 10.3390/ijms23158088. Int J Mol Sci. 2022. PMID: 35897667 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical